MyoKardia Inc (MYOK.OQ)
24 Nov 2017
Fri, Nov 3 2017
* MyoKardia Inc reports third quarter 2017 financial results and operational progress
* MyoKardia Inc - next trial of MYK-491 in DCM patients expected to initiate by year-end
* MyoKardia announces pricing of public offering of common stock
* Commenced a proposed underwritten public offering of 3.5 million shares of its common stock Source text for Eikon: Further company coverage:
Shares of MyoKardia Inc hit a record high on Monday after the company said its experimental drug for an inherited heart disease met the main goal in a small mid-stage study.
* Myokardia reports second quarter 2017 financial results and operational progress
* Myokardia Inc files for offering of up to 9.2 shares of common stock by the selling stockholders - sec filing
- A Current Look At The ROTY Contenders List
- Editors' Picks Daily: Healthcare REITs, Challenging The AT&T/Time Warner Merger
- MyoKardia: Buy The Dip
- MyoKardia (MYOK) Presents At Stifel 2017 Healthcare Conference - Slideshow
- MyoKardia's (MYOK) CEO Tassos Gianakakos on Q3 2017 Results - Earnings Call Transcript
- The Small Cap Rush!